Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inspiremd Inc (NQ: NSPR ) 2.550 +0.040 (+1.59%) Streaming Delayed Price Updated: 3:59 PM EST, Nov 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Inspiremd Inc < Previous 1 2 3 Next > Earnings Scheduled For March 6, 2024 March 06, 2024 Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. Via Benzinga Preview: InspireMD's Earnings March 05, 2024 Via Benzinga Earnings Scheduled For November 6, 2023 November 06, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. Via Benzinga InspireMD Earnings Preview November 03, 2023 Via Benzinga Why Are InspireMD Shares Surging Today May 15, 2023 Via Benzinga Earnings Scheduled For November 12, 2024 November 12, 2024 Via Benzinga NSPR Stock Earnings: InspireMD Misses EPS, Misses Revenue for Q2 2024 August 06, 2024 NSPR stock results show that InspireMD missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. Via InvestorPlace NSPR Stock Earnings: InspireMD Misses EPS, Beats Revenue for Q1 2024 May 14, 2024 NSPR stock results show that InspireMD missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace NSPR Stock Earnings: InspireMD Beats EPS, Beats Revenue for Q4 2023 March 06, 2024 NSPR stock results show that InspireMD beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session August 23, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session July 21, 2023 Via Benzinga InspireMD's Return On Capital Employed Insights March 31, 2023 Via Benzinga InspireMD: Q2 Earnings Insights August 09, 2022 InspireMD (NASDAQ:NSPR) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Via Benzinga Recap: InspireMD Q1 Earnings May 10, 2022 InspireMD (NASDAQ:NSPR) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session July 12, 2023 Via Benzinga Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 12, 2023 Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session June 30, 2023 Via Benzinga Recap: InspireMD Q4 Earnings March 08, 2022 InspireMD (NASDAQ:NSPR) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings... Via Benzinga InspireMD: Q4 Earnings Insights March 08, 2022 InspireMD (NASDAQ:NSPR) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023 June 12, 2023 Via Benzinga Earnings Scheduled For March 30, 2023 March 30, 2023 Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million. Via Benzinga Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session May 15, 2023 Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday October 26, 2022 On Wednesday, 53 companies reached new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday November 04, 2022 Friday's session saw 236 companies set new 52-week lows. Via Benzinga $7.3 Million Bet On This Penny Stock? Check Out These 4 Penny Stocks Insiders Are Buying August 23, 2022 The Dow Jones dropped more than 600 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... Via Benzinga 5 Stocks To Watch For June 6, 2022 June 06, 2022 Some of the stocks that may grab investor focus today are: Via Benzinga Looking Into InspireMD's Return On Capital Employed March 10, 2022 InspireMD (AMEX:NSPR) brought in sales totaling $1.38 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 0.64%, resulting in a loss of $4.10... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session March 08, 2022 Gainers Stealth BioTherapeutics (NASDAQ:MITO) shares increased by 22.1% to $0.65 during Tuesday's pre-market session. The company's market cap stands at $37.4... Via Benzinga The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout March 08, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative... Via Benzinga Earnings Scheduled For March 8, 2022 March 08, 2022 Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
